Literature DB >> 26647262

Interventions for Rosacea.

Esther J van Zuuren1, Zbys Fedorowicz2.   

Abstract

CLINICAL QUESTION: Which interventions are associated with highest efficacy and fewest adverse events for treating rosacea? BOTTOM LINE: There is high-quality evidence that topical brimonidine, azelaic acid, and ivermectin, as well as oral doxycycline and isotretinoin, are associated with improvements in rosacea. Lower-quality evidence is available for topical metronidazole, oral tetracycline, laser and light-based therapy, and topical cyclosporine for ocular rosacea. Most treatments are not associated with higher adverse event rates than placebo.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26647262     DOI: 10.1001/jama.2015.15287

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  4 in total

Review 1.  Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

Review 2.  Managing Rosacea in the Clinic: From Pathophysiology to Treatment-A Review of the Literature.

Authors:  Sandra Marchese Johnson; Andrew Berg; Chelsea Barr
Journal:  J Clin Aesthet Dermatol       Date:  2020-04-01

Review 3.  Recent advances in understanding and managing rosacea.

Authors:  Joerg Buddenkotte; Martin Steinhoff
Journal:  F1000Res       Date:  2018-12-03

Review 4.  Safety of antimalarial medications for use while scuba diving in malaria Endemic Regions.

Authors:  Kyle Petersen; David P Regis
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.